You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普華和順(01358.HK)擬出售所持有532.1萬股CBPO股份
格隆匯 10-27 06:36

格隆匯 10 月 27日丨普華和順(01358.HK)發佈公告,2020年10月26日,公司(作為賣方)分別與Biomedical Treasure 、 CITIC Capital及Biomedical Future各自訂立三份股份購買協議,以每股CBPO股份120.0美元的出售價格出售其所持有的合共532.1萬股CBPO股份,相當於其於CBPO的全部持股量。

股東在股東特別大會上批准出售事項後,公司擬不再繼續進行私有化中有關公司的存續交易及在切實可行情況下儘快完成出售事項。預期公司及其他財團成員將於簽署合併協議的時間前後簽署經修訂及重列財團協議,預期當中將規定財團協議將於出售事項完成後對公司終止。

CBPO為一間於中國主要從事研發、生產及銷售血液生物製品或血液製品的生物製藥公司。CBPO自2009年起於納斯達克上市,並已於2017年7月21日將註冊地點由特拉華州改為開曼羣島。緊接訂立股份購買協議前,公司持有532.1萬股CBPO股份,相當於CBPO所有已發行及發行在外股本的13.79%。緊隨出售事項交割後,公司將不會持有任何CBPO的股權(假設由股份購買協議日期起至出售事項交割止,CBPO當前的股本及股權架構並無其他變動)。股份購買協議下的出售價格每股CBPO股份120.0美元較每股CBPO股份截至2020年10月23日在納斯達克的收市價溢價約6.03%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account